Whether Early-stage (N0 Neck) Oral Cancer Patients Received Primary Tumor Resection Without Neck Dissection Benefit from Immune Checkpoint Therapy

Overview

Journal Int J Surg

Specialty General Surgery

Date 2023 Nov 23

PMID 37994732

Authors

Wei Liu

Xuemin Shen

Linjun Shi

Yue He

Affiliations

Soon will be listed here.

Citing Articles

3D printing materials and 3D printed surgical devices in oral and maxillofacial surgery: design, workflow and effectiveness.

Wang X, Mu M, Yan J, Han B, Ye R, Guo G Regen Biomater. 2024; 11:rbae066.

PMID: 39169972 PMC: 11338467. DOI: 10.1093/rb/rbae066.

References

Jiang S, Liu Y, Zheng H, Zhang L, Zhao H, Sang X . Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis. Int J Surg. 2023; 109(9):2774-2783. PMC: 10498839. DOI: 10.1097/JS9.0000000000000492. View

Cai H, Zhu Y, Wang C, Zhang Y, Hou J . Neck nodal recurrence and survival of clinical T1-2 N0 oral squamous cell carcinoma in comparison of elective neck dissection versus observation: A meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020; 129(4):296-310. DOI: 10.1016/j.oooo.2019.10.012. View

Akheel M, George R, Tiwari S, Jain A, Chahwala Q, Wadhwania A . Elective Neck Dissection Versus Observation in cT1-T2 Oral Tongue Squamous Cell Carcinoma: A Meta-Analysis of 11,973 Patients. Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):2256-2264. PMC: 9701936. DOI: 10.1007/s12070-020-02118-y. View

Cao Y, Wang T, Yu C, Guo X, Li C, Li L . Elective Neck Dissection Versus Wait-and-Watch Policy for Oral Cavity Squamous Cell Carcinoma in Early Stage: A Systematic Review and Meta-Analysis Based on Survival Data. J Oral Maxillofac Surg. 2019; 77(10):2154-2167. DOI: 10.1016/j.joms.2019.03.015. View

Liu J, Chen C, Bai C . Elective Neck Dissection Versus Observation in Early-Stage (cT1/T2N0) Oral Squamous Cell Carcinoma. Laryngoscope Investig Otolaryngol. 2019; 4(5):554-561. PMC: 6793606. DOI: 10.1002/lio2.301. View

Fasano M, Della Corte C, Di Liello R, Viscardi G, Sparano F, Iacovino M . Immunotherapy for head and neck cancer: Present and future. Crit Rev Oncol Hematol. 2022; 174:103679. DOI: 10.1016/j.critrevonc.2022.103679. View

Rahim M, Okholm T, Jones K, McCarthy E, Liu C, Yee J . Dynamic CD8 T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell. 2023; 186(6):1127-1143.e18. PMC: 10348701. DOI: 10.1016/j.cell.2023.02.021. View

Chuang S, Lee K . Elective neck dissection may not necessarily reduce recurrence and improve survival in all cases of early stage (CT1/2 N0 M0) oral squamous cell carcinoma. J Evid Based Dent Pract. 2021; 21(2):101573. DOI: 10.1016/j.jebdp.2021.101573. View

Kumar A, Ghai S, Mhaske S, Singh R . Elective Neck Dissection Versus Therapeutic Neck Dissection in Clinically Node-Negative Early Stage Oral Cancer: A Meta-analysis of Randomized Controlled Trials. J Maxillofac Oral Surg. 2022; 21(2):340-349. PMC: 9192853. DOI: 10.1007/s12663-021-01677-z. View

10.

Massey C, Dharmarajan A, Bannuru R, Rebeiz E . Management of N0 neck in early oral squamous cell carcinoma: A systematic review and meta-analysis. Laryngoscope. 2018; 129(8):E284-E298. DOI: 10.1002/lary.27627. View

11.

Chamoli A, Gosavi A, Shirwadkar U, Wangdale K, Behera S, Kurrey N . Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021; 121:105451. DOI: 10.1016/j.oraloncology.2021.105451. View

12.

Chegini S, Schilling C, Walgama E, Yu K, Thankappan K, Iyer S . Neck failure following pathologically node-negative neck dissection (pN0) in oral squamous cell carcinoma: a systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2021; 59(10):1157-1165. DOI: 10.1016/j.bjoms.2021.04.002. View

13.

Ibrahim S, Ahmed A, Elsersy H, Darahem I . Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: essential or not? A systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2020; 277(6):1741-1752. DOI: 10.1007/s00405-020-05866-3. View

14.

Reticker-Flynn N, Engleman E . Lymph nodes: at the intersection of cancer treatment and progression. Trends Cell Biol. 2023; 33(12):1021-1034. PMC: 10624650. DOI: 10.1016/j.tcb.2023.04.001. View

15.

Oh L, Phan K, Kim S, Low T, Gupta R, Clark J . Elective neck dissection versus observation for early-stage oral squamous cell carcinoma: Systematic review and meta-analysis. Oral Oncol. 2020; 105:104661. DOI: 10.1016/j.oraloncology.2020.104661. View

16.

Ding Z, Xiao T, Huang J, Yuan Y, Ye Q, Xuan M . Elective Neck Dissection Versus Observation in Squamous Cell Carcinoma of Oral Cavity With Clinically N0 Neck: A Systematic Review and Meta-Analysis of Prospective Studies. J Oral Maxillofac Surg. 2018; 77(1):184-194. DOI: 10.1016/j.joms.2018.08.007. View

17.

Kong X, Chen L, Su Z, Sullivan R, Blum S, Qi Z . Toxicities associated with immune checkpoint inhibitors: a systematic study. Int J Surg. 2023; 109(6):1753-1768. PMC: 10389211. DOI: 10.1097/JS9.0000000000000368. View

18.

Yilmaz E, Ismaila N, Bauman J, Dabney R, Gan G, Jordan R . Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. J Clin Oncol. 2022; 41(5):1132-1146. DOI: 10.1200/JCO.22.02328. View

19.

Nindra U, Hurwitz J, Forstner D, Chin V, Gallagher R, Liu J . A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma. Cancer Med. 2023; 12(10):11234-11247. PMC: 10242857. DOI: 10.1002/cam4.5815. View